Amplity Health, a leading global medical and commercial partner to biopharmaceutical companies, today announced the appointment of Dan Cusack to Principal, Market Access, to lead the commercial vertical of Amplity's Market Access practice. Cusack's appointment follows Amplity's recent acquisition of Middleton Access, whose capabilities strengthened Amplity's Consulting service to form a differentiated offering that both builds and executes payer strategy.
"We have bold ambitions to offer innovative and creative data-driven solutions for our pharmaceutical and biotech clients," explains Cheryl Nagowski, Head of Market Access. "Dan brings a thoughtful and sophisticated approach to access challenges. He provides the energy and talent we need to navigate this challenging landscape and evolve our commercial solutions."
Leveraging years of deep industry experience and knowledge of data and market research, Cusack will support Amplity's clients by developing actionable strategies for new market entry, preparing for competition, and lowering barriers to commercial access for their patients
Cusack has many years' experience in the pharmaceutical industry with successes built upon strong clinical knowledge, health system and payer insights, and relationships among commercial and governmental channels.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.